Moreover, the 36-month beta value for IRTC is 1.33. Analysts have varying opinions on the stock, with 8 analysts rating it as a “buy,” 3 as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for IRTC is 30.61M and currently, short sellers hold a 9.59% of that float. On April 18, 2025, IRTC’s average trading volume was 426.85K shares.
IRTC) stock’s latest price update
iRhythm Technologies Inc (NASDAQ: IRTC)’s stock price has gone rise by 1.01 in comparison to its previous close of 99.95, however, the company has experienced a 2.20% increase in its stock price over the last five trading days. globenewswire.com reported 2025-04-17 that SAN FRANCISCO, April 17, 2025 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2025 after the close of trading on Thursday, May 1, 2025. The company’s management team will host a corresponding conference call beginning at 1:30 p.m.
IRTC’s Market Performance
iRhythm Technologies Inc (IRTC) has experienced a 2.20% rise in stock performance for the past week, with a -2.09% drop in the past month, and a -5.64% drop in the past quarter. The volatility ratio for the week is 4.14%, and the volatility levels for the past 30 days are at 5.25% for IRTC. The simple moving average for the past 20 days is -2.24% for IRTC’s stock, with a 14.07% simple moving average for the past 200 days.
Analysts’ Opinion of IRTC
Many brokerage firms have already submitted their reports for IRTC stocks, with Wells Fargo repeating the rating for IRTC by listing it as a “Equal Weight.” The predicted price for IRTC in the upcoming period, according to Wells Fargo is $86 based on the research report published on December 03, 2024 of the previous year 2024.
Goldman, on the other hand, stated in their research note that they expect to see IRTC reach a price target of $78. The rating they have provided for IRTC stocks is “Neutral” according to the report published on October 04th, 2024.
Wolfe Research gave a rating of “Outperform” to IRTC, setting the target price at $115 in the report published on June 20th of the previous year.
IRTC Trading at -4.65% from the 50-Day Moving Average
After a stumble in the market that brought IRTC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -21.44% of loss for the given period.
Volatility was left at 5.25%, however, over the last 30 days, the volatility rate increased by 4.14%, as shares sank -3.24% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -9.14% lower at present.
During the last 5 trading sessions, IRTC rose by +2.20%, which changed the moving average for the period of 200-days by -5.16% in comparison to the 20-day moving average, which settled at $103.27. In addition, iRhythm Technologies Inc saw 11.97% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at IRTC starting from Blackford Quentin S., who sale 8,145 shares at the price of $108.77 back on Mar 03 ’25. After this action, Blackford Quentin S. now owns 208,741 shares of iRhythm Technologies Inc, valued at $885,932 using the latest closing price.
Rosenbaum Marc W., the Chief Accounting Officer of iRhythm Technologies Inc, sale 314 shares at $108.77 during a trade that took place back on Mar 03 ’25, which means that Rosenbaum Marc W. is holding 11,507 shares at $34,154 based on the most recent closing price.
Stock Fundamentals for IRTC
Current profitability levels for the company are sitting at:
- -0.2 for the present operating margin
- 0.69 for the gross margin
The net margin for iRhythm Technologies Inc stands at -0.19. The total capital return value is set at -0.14. Equity return is now at value -75.27, with -16.60 for asset returns.
Based on iRhythm Technologies Inc (IRTC), the company’s capital structure generated 0.89 points at debt to capital in total, while cash flow to debt ratio is standing at 0.0. The debt to equity ratio resting at 8.11. The interest coverage ratio of the stock is -9.01.
Currently, EBITDA for the company is -74.13 million with net debt to EBITDA at -3.65. When we switch over and look at the enterprise to sales, we see a ratio of 5.89. The receivables turnover for the company is 7.4for trailing twelve months and the total asset turnover is 0.64. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.82.
Conclusion
To wrap up, the performance of iRhythm Technologies Inc (IRTC) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
